Contents
Key findings
- 1Semax and Selank are the two peptides most sold for focus, memory and calm.
- 2Selank has clinical studies as an anti-anxiety agent, reportedly calming without the sedation or dependence of benzodiazepines.
- 3Semax is studied for attention, memory and stroke recovery, and raises brain growth factors like BDNF in lab work.
- 4The catch is big - nearly all the human research is Russian, often small, and has not been independently replicated in the West.
- 5Neither is FDA-approved; both are sold as unapproved research peptides outside Russia.
Evidence level
Semax and Selank have decades of clinical use in Russia, with studies suggesting benefits for attention, memory and anxiety. The big limit is that nearly all of that research is Russian, often small, and has not been independently replicated in the West.
Regulatory status
Semax and Selank are not FDA-approved for any use. They are approved and used clinically in Russia, and are sold elsewhere as unapproved research peptides.
Search for "nootropic peptides" and two names come up again and again: Semax and Selank. They are interesting - and, unusually, they have real clinical use behind them. The honest catch is where that evidence comes from, and how much of it has held up outside one country.
The two names you'll actually see
- Selank - marketed for calm and anti-anxiety without the fog.
- Semax - marketed for focus, memory, and mental energy.
Both are peptides originally developed and used clinically in Russia, and both are sold elsewhere as research peptides for cognitive enhancement.
Selank — the calming one
Selank is studied as an anxiolytic (anti-anxiety) peptide. In clinical research, it reportedly reduced anxiety on par with a benzodiazepine (medazepam), but without the sedation, memory impairment, or dependence that benzodiazepines are known for - and with some mild anti-fatigue and stimulating effects[1].
If that holds up, it would be genuinely useful - calm without the downsides. The honest caveat is exactly that "if": the evidence is small and Russian, and Western researchers have not independently confirmed it.
Grade: preliminary.
Semax — the focus one
Semax is studied for attention, memory, and recovery after stroke, and in laboratory work it raises brain growth factors like BDNF (which supports learning and memory). Russian clinical research has looked at it in stroke patients, children with developmental delay, and other conditions, reporting improvements in attention and processing speed.
Same pattern, same caveat: the results are promising and mostly Russian, and they have not been replicated by independent Western trials.
Grade: preliminary.
Why the "mostly Russian" point matters
This is not about dismissing Russian science. It is about a basic rule of evidence: findings are more trustworthy when different, independent groups reproduce them. For Semax and Selank, that independent replication has largely not happened outside Russia - so the honest label is "interesting and clinically used in one country," not "proven by the usual global standard."
The bottom line
For focus and cognition, Semax and Selank are the peptides with actual clinical histories - which is more than most "nootropic" pills can say. But "clinically used in Russia" and "proven by independent global trials" are different bars, and these clear the first, not the second. Interesting, preliminary, and unregulated outside Russia.
Where to go next
- Cognitive research hub
- How to read peptide research
- FDA-approved, off-label, investigational and unapproved peptides
- Peptide safety hub
Frequently asked questions
- What are the best peptides for focus and cognition?
- Semax and Selank are the two most commonly sold for focus, memory and calm. Both have clinical studies suggesting benefits, but nearly all of that research is Russian, often small, and not independently replicated in the West - so treat the evidence as preliminary.
- Does Selank work for anxiety?
- Russian clinical studies report that Selank reduces anxiety similarly to a benzodiazepine, but without the sedation, memory problems, or dependence. That is encouraging, but the evidence base is small and has not been replicated by Western researchers.
- Does Semax improve memory and focus?
- Russian studies and lab work suggest Semax can improve attention and memory and raises brain growth factors like BDNF. Again, the evidence is mostly Russian and preliminary - promising signals, not proven benefits by Western standards.
- Are Semax and Selank FDA-approved?
- No. Neither is FDA-approved. They are approved and used clinically in Russia, but elsewhere they are sold as unapproved research peptides of unregulated quality.
References
Numbered in order of first use. Study type is shown for every source; see our methodology for how we rank evidence.
- 1.
Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia Zhurnal Nevrologii i Psikhiatrii (PubMed 18454096), 2008.
Human study
Result: A clinical study reported that selank had anxiety-reducing effects comparable to the benzodiazepine medazepam, with additional anti-fatigue and mild stimulating effects and without the cognitive impairment associated with benzodiazepines.
↑ back to text
Review status: Editorially reviewed against primary sources. This article was fact-checked against the primary sources listed in the references by our editorial team, and it has not been reviewed by a licensed clinician. It is educational content, not medical advice. Read our editorial policy and methodology. Spotted an error? Tell us.
